Biogen and Sage Navigate Setbacks After Zuranolone Ruling

أضاف وظيفة جديدة Health

2025-02-05 07:33:51 - ترجمة -

Biogen and Sage Therapeutics’ highly anticipated drug, Zuranolone, has been the subject of both celebration and disappointment. The Zuranolone FDA approval for treating postpartum depression (PPD) marked a significant step forward in the development of novel psychiatric treatments. However, the simultaneous rejection of its application for major depressive disorder (MDD) has...

0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة